VISTAGEN THERAPEUTICS, INC. Net Income (Loss) Attributable to Parent, Diluted
VISTAGEN THERAPEUTICS, INC. (VTGN) reported Net Income (Loss) Attributable to Parent, Diluted of -$3.45 million for the 3-month period ending 2015-12-31, per its 10-Q filed 2016-02-16.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToParentDiluted · last filed 2016-02-16
- VISTAGEN THERAPEUTICS, INC. net income (loss) attributable to parent, diluted for the quarter ending 2015-12-31 was -$3.45M.
- VISTAGEN THERAPEUTICS, INC. net income (loss) attributable to parent, diluted for the quarter ending 2015-09-30 was -$8.55M.
- VISTAGEN THERAPEUTICS, INC. net income (loss) attributable to parent, diluted for the quarter ending 2014-12-31 was -$1.41M.
- VISTAGEN THERAPEUTICS, INC. net income (loss) attributable to parent, diluted for the quarter ending 2014-09-30 was -$2.46M.
| Period end | Net Income (Loss) Attributable to Parent, Diluted 3 month | Net Income (Loss) Attributable to Parent, Diluted 6 month | Net Income (Loss) Attributable to Parent, Diluted 9 month |
|---|---|---|---|
| 2015-12-31 | -$3.45M 10-Q · filed 2016-02-16 | -$12.00M derived: sum of 2 quarters · filed 2016-02-16 | -$41.99M 10-Q · filed 2016-02-16 |
| 2015-09-30 | -$8.55M 10-Q · filed 2015-11-16 | -$38.54M 10-Q · filed 2015-11-16 | |
| 2014-12-31 | -$1.41M 10-Q · filed 2016-02-16 | -$3.87M derived: sum of 2 quarters · filed 2016-02-16 | -$7.92M 10-Q · filed 2016-02-16 |
| 2014-09-30 | -$2.46M 10-Q · filed 2015-11-16 | -$6.57M 10-Q · filed 2015-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |